000 | 01733 a2200541 4500 | ||
---|---|---|---|
005 | 20250514195750.0 | ||
264 | 0 | _c20041209 | |
008 | 200412s 0 0 eng d | ||
022 | _a0264-410X | ||
024 | 7 |
_a10.1016/j.vaccine.2004.02.046 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aJarrosson, L | |
245 | 0 | 0 |
_aMost humoral non-responders to hepatitis B vaccines develop HBV-specific cellular immune responses. _h[electronic resource] |
260 |
_bVaccine _cSep 2004 |
||
300 |
_a3789-96 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 |
_aAntibody Formation _xgenetics |
650 | 0 | 4 | _aCD4-CD8 Ratio |
650 | 0 | 4 |
_aCell Division _xphysiology |
650 | 0 | 4 |
_aCytokines _xbiosynthesis |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aGenotype |
650 | 0 | 4 | _aHealth Personnel |
650 | 0 | 4 |
_aHepatitis B Surface Antigens _ximmunology |
650 | 0 | 4 |
_aHepatitis B Vaccines _ximmunology |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aImmunity, Cellular _xgenetics |
650 | 0 | 4 | _aImmunization, Secondary |
650 | 0 | 4 |
_aLymphocytes _xphysiology |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aOccupational Exposure |
650 | 0 | 4 | _aPhenotype |
650 | 0 | 4 | _aPolymorphism, Genetic |
650 | 0 | 4 |
_aT-Lymphocytes _ximmunology |
650 | 0 | 4 |
_aTh1 Cells _ximmunology |
650 | 0 | 4 |
_aTh2 Cells _ximmunology |
700 | 1 | _aKolopp-Sarda, M N | |
700 | 1 | _aAguilar, P | |
700 | 1 | _aBéné, M C | |
700 | 1 | _aLepori, M L | |
700 | 1 | _aVignaud, M C | |
700 | 1 | _aFaure, G C | |
700 | 1 | _aKohler, C | |
773 | 0 |
_tVaccine _gvol. 22 _gno. 27-28 _gp. 3789-96 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.vaccine.2004.02.046 _zAvailable from publisher's website |
999 |
_c15014677 _d15014677 |